Literature DB >> 3863141

Gene mapping and leader polypeptide sequence of human glucocerebrosidase: implications for Gaucher disease.

E I Ginns, P V Choudary, S Tsuji, B Martin, B Stubblefield, J Sawyer, J Hozier, J A Barranger.   

Abstract

Analysis of immunologic cross-reacting material in Chinese hamster-human somatic cell hybrids allowed assignment of the structural gene for glucocerebrosidase (glucosylceramidase; beta-D-glucosyl-N-acylsphingosine glucohydrolase, EC 3.2.1.45) to chromosome 1 bands q21-q32. In situ hybridization of a radiolabeled human glucocerebrosidase cDNA to high resolution human chromosomes demonstrated that a single locus encoding glucocerebrosidase is on 1q21, adjacent to a region of chromosome 1 (1qh) abundant in structural heteromorphisms. We also have identified a hydrophobic leader polypeptide encoded by this locus, permitting a more complete description of the biosynthesis of the enzyme. These results suggest that the type-specific protein polymorphisms in Gaucher disease result from mutations at this single locus, whose segregation might be followed by linkage to visible chromosomal heteromorphisms.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3863141      PMCID: PMC391318          DOI: 10.1073/pnas.82.20.7101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Protein translocation across the endoplasmic reticulum.

Authors:  P Walter; R Gilmore; G Blobel
Journal:  Cell       Date:  1984-08       Impact factor: 41.582

3.  Isolation of cDNA clones for human beta-glucocerebrosidase using the lambda gt11 expression system.

Authors:  E I Ginns; P V Choudary; B M Martin; S Winfield; B Stubblefield; J Mayor; D Merkle-Lehman; G J Murray; L A Bowers; J A Barranger
Journal:  Biochem Biophys Res Commun       Date:  1984-09-17       Impact factor: 3.575

Review 4.  Compilation of published signal sequences.

Authors:  M E Watson
Journal:  Nucleic Acids Res       Date:  1984-07-11       Impact factor: 16.971

5.  Complementation analysis in Gaucher disease using single cell microassay techniques. Evidence for a single "Gaucher gene".

Authors:  R A Gravel; A Leung
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

6.  Mutations of glucocerebrosidase: discrimination of neurologic and non-neurologic phenotypes of Gaucher disease.

Authors:  E I Ginns; R O Brady; S Pirruccello; C Moore; S Sorrell; F S Furbish; G J Murray; J Tager; J A Barranger
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

7.  Determination of Gaucher's disease phenotypes with monoclonal antibody.

Authors:  E I Ginns; F P Tegelaers; R Barneveld; H Galjaard; A J Reuser; R O Brady; J M Tager; J A Barranger
Journal:  Clin Chim Acta       Date:  1983-07-15       Impact factor: 3.786

8.  Assignment of the gene coding for human beta-glucocerebrosidase to the region q21-q31 of chromosome 1 using monoclonal antibodies.

Authors:  R A Barneveld; W Keijzer; F P Tegelaers; E I Ginns; A Geurts van Kessel; R O Brady; J A Barranger; J M Tager; H Galjaard; A Westerveld; A J Reuser
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

9.  Regional assignment of the structural gene for human acid beta-glucosidase to q42 leads to qter on chromosome 1.

Authors:  E A Devine; M Smith; F X Arredondo-Vega; B Shafit-Zagardo; R J Desnick
Journal:  Cytogenet Cell Genet       Date:  1982

10.  Polymorphism of human constitutive heterochromatin.

Authors:  A P Craig-Holmes; M W Shaw
Journal:  Science       Date:  1971-11-12       Impact factor: 47.728

View more
  29 in total

1.  Chromosomal mapping of the high affinity Fc gamma receptor gene.

Authors:  R J Oakey; T A Howard; P M Hogarth; K Tani; M F Seldin
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

2.  Dolphin beta-glucocerebrosidase, map position 1q22.

Authors:  P Bielec; D Gallagher; J Womack; J Taylor; S Davis; D Busbee
Journal:  Chromosome Res       Date:  1998-08       Impact factor: 5.239

3.  Generation of polyclonal antibodies against recombinant human glucocerebrosidase produced in Escherichia coli.

Authors:  Juliana Branco Novo; Maria Leonor Sarno Oliveira; Geraldo Santana Magalhães; Ligia Morganti; Isaías Raw; Paulo Lee Ho
Journal:  Mol Biotechnol       Date:  2010-11       Impact factor: 2.695

Review 4.  Pathogenesis of lysosomal storage disorders as illustrated by Gaucher disease.

Authors:  J M Aerts; S Van Weely; R Boot; C E Hollak; J M Tager
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

5.  Gaucher's disease in the United Kingdom: screening non-Jewish patients for the two common mutations.

Authors:  A J Walley; M L Barth; I Ellis; A H Fensom; A Harris
Journal:  J Med Genet       Date:  1993-04       Impact factor: 6.318

Review 6.  Gaucher disease as a paradigm of current issues regarding single gene mutations of humans.

Authors:  E Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

7.  A glucocerebrosidase fusion gene in Gaucher disease. Implications for the molecular anatomy, pathogenesis, and diagnosis of this disorder.

Authors:  A Zimran; J Sorge; E Gross; M Kubitz; C West; E Beutler
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

8.  Phenotypic and genotypic heterogeneity in gaucher disease: Implications for genetic counseling.

Authors:  E Sidransky; E I Ginns
Journal:  J Genet Couns       Date:  1994-03       Impact factor: 2.537

Review 9.  Chromosome 1 in relation to human disease.

Authors:  S Povey; J M Parrington
Journal:  J Med Genet       Date:  1986-04       Impact factor: 6.318

10.  Association of a new chromosomal deletion [del(1)(q32q42)] with diaphragmatic hernia: assignment of a human ferritin gene.

Authors:  H Youssoufian; P Chance; C M Tuck-Muller; E W Jabs
Journal:  Hum Genet       Date:  1988-03       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.